(Total Views: 386)
Posted On: 05/16/2019 9:57:21 AM
Post# of 72441
Excellent news, YES!!! Interesting that I had this thought just last evening...
I would have rather seen the PR say it was for OM but moving Brilacidin forward is the ultimate goal. And who's to say OM isn't in the picture with this global pharma. Possibly that is from the 1st term sheet!
https://finance.yahoo.com/news/innovation-pha...00027.html
BEVERLY, Mass., May 16, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term sheet with a global pharmaceutical company to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.
The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.
Completion of the transaction, as specified in the non-binding term sheet, is subject to further negotiation and execution of a definitive agreement. If the definitive agreement is reached and signed, the Company anticipates that it would receive an upfront payment, plus potential additional regulatory and commercial milestone payments, as well as royalties.
Very cool!
GO $IPIX!!!
Quote:
I use to follow someone that searched and had a great eye for mergers and such.
Anyway, the last offering was taken up pretty quick, like it was already planned. So far we haven't seen anyone step up. Very well we could be getting the deal inked.
Jmo.
Read More: https://investorshangout.com/post/view?id=543...z5o5zTtKW1
I would have rather seen the PR say it was for OM but moving Brilacidin forward is the ultimate goal. And who's to say OM isn't in the picture with this global pharma. Possibly that is from the 1st term sheet!
https://finance.yahoo.com/news/innovation-pha...00027.html
BEVERLY, Mass., May 16, 2019 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has signed a non-binding term sheet with a global pharmaceutical company to develop and commercialize locally-administered Brilacidin (e.g., foam, enema, gel), on a worldwide basis, for the treatment of Ulcerative Proctitis/Ulcerative Proctosigmoiditis.
The non-binding term sheet also includes a Right of First Refusal for rights to Brilacidin for the treatment of more extensive forms of Inflammatory Bowel Disease, such as Ulcerative Colitis and Crohn’s Disease, and a Right of First Negotiation for rights to Brilacidin in other Gastrointestinal (GI) indications.
Completion of the transaction, as specified in the non-binding term sheet, is subject to further negotiation and execution of a definitive agreement. If the definitive agreement is reached and signed, the Company anticipates that it would receive an upfront payment, plus potential additional regulatory and commercial milestone payments, as well as royalties.
Very cool!
GO $IPIX!!!
(0)
(0)Scroll down for more posts ▼
